Douglas C. Wolf

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

Veterinary Medicine, Immunology, Pharmacotherapy +12

Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

Bruce E. Sands, Frank Anderson, Çharles N. Bernstein et al. · New England Journal of Medicine · 2004 · 2.2K citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

Stephen B. Hanauer, William J. Sandborn, Paul Rutgeerts et al. · Gastroenterology · 2006 · 1.7K citations

Life Sciences, Immunology, Internal Medicine +13

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

William J. Sandborn, Gert Van Assche, Walter Reinisch et al. · Gastroenterology · 2011 · 1.3K citations

Life Sciences, Clinical Sciences, Immunology +16

Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial

William J. Sandborn, S. B. Hanauer, P. Rutgeerts et al. · Gut · 2007 · 1K citations · Full text

Medicine, Clinical Sciences, Pharmacology +16